Chemical formula: C₅H₉Cl₂N₃O₂ Molecular mass: 214.05 g/mol PubChem compound: 2578
Carmustine is indicated for:
Population group: only adults (18 years old or older)
Carmustine is effective in brain tumours (glioblastoma, Brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Carmustine is effective in secondary therapy in non-Hodgkin’s lymphoma and Hodgkin’s disease as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Carmustine is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.